ArticleCancer biology & medicine2018

Primary resistance to crizotinib treatment in a non-small cell lung cancer patient with an EML4-ALK rearrangement: a case report.

Ling Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.